U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Approved Blood Products
  5. AFSTYLA
  1. Approved Blood Products

AFSTYLA

STN#: BL 125591
Proper Name: Antihemophilic Factor (Recombinant), Single Chain
Tradename: AFSTYLA
Manufacturer: CSL Behring GmbH
Indication:  For adults and children with hemophilia A (congenital Factor VIII deficiency) for:

  • On-demand treatment and control of bleeding episodes,
  • Routine prophylaxis to reduce the frequency of bleeding episodes,
  • Perioperative management of bleeding.

Product Information

Supporting Documents

Back to Top